Drug Report History #141615
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v4-FR | Version v3-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2021-07-20 | 2021-07-20 |
| Drug Identification Number | 02487020 | 02487020 |
| Brand name | ENGERIX-B | ENGERIX-B |
| Common or Proper name | Hepatitis B vaccine (recombinant) | Hepatitis B vaccine (recombinant) |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | HEPATITIS B SURFACE ANTIGEN | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG | 10MCG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1s | 1s |
| ATC code | J07BC | J07BC |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2021-06-23 | 2021-06-23 |
| Estimated end date | 2021-08-13 | 2021-08-13 |
| Actual end date | 2021-07-19 | 2021-07-19 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Limited supply available for public programs. Supply unavailable for the private market. | Limited supply available for public programs. Supply unavailable for the private market. |
| Health Canada comments |